Pulmonary infiltrates during community acquired Gram-negative bacteremia: a retrospective single centre study
© Fjeldsøe-Nielsen et al.; licensee BioMed Central Ltd. 2013
Received: 30 September 2013
Accepted: 8 December 2013
Published: 17 December 2013
The primary aim of this study was to describe the frequency of pulmonary infiltrates on chest X-ray (CXR) during community acquired Gram-negative bacteremia at a single centre in Denmark.
The patients were retrospectively identified from the laboratory information system and clinical and radiological data were retrieved from the electronic health records. Overall 114 patients with E.coli or K.pneumoniae bacteremia fulfilled the inclusion criteria during the period 2009–2010.
CXR was performed in 77% of cases (80% of E.coli and 56% of K.pneumoniae) among which infiltrates were identified in 34%. The two most frequent localizations of infiltrates during E.coli bacteremia were lower lobe/basal (56%) and diffuse (22%). Furthermore, 30% of infiltrates were bilateral while 40% were present on the right lung and 30% on the left lung.
In conclusion, the presence of infiltrates during community acquired Gram-negative bacteremia was very frequent in our population.
KeywordsGram-negative bacteremia Pulmonary infiltrates Urosepsis Lipopolysaccharide Flagellin
Patients admitted to hospital with sepsis and pulmonary infiltrates may have bacterial pneumonia, however, this is not always the case. The recommended treatment of community acquired pneumonia in Denmark is still in most cases penicillin taking into account disease severity and patient characteristics. The recommended treatment of urosepsis includes a broader spectrum beta-lactam antibiotic covering the most common Enterobacteriacae. It is well known that appropriate antibiotic treatment on admission reduces mortality during severe sepsis and septic shock. Therefore, the primary diagnosis and early focus identification is crucial in order to initiate appropriate empiric antibiotic treatment while waiting for microbiologic results. The primary purpose of this study was to determine how often pulmonary infiltrates are identified on chest X-ray (CXR) during community acquired Gram-negative bacteremia.
Patients admitted to the emergency department at Nykoebing Falster Hospital with bacteremia with E.coli or K.pneumoniae during the period January 2009 to December 2010 were included in the study retrospectively. Patients with multiple bacteremic episodes were only included with the first episode fulfilling the inclusion criteria. Episodes with more than one isolated microorganism were excluded. Patients under the age of 14 years were excluded. CXR and microbiologic samples taken within 2 days of the positive blood culture were studied. CXR was considered positive by the authors if the radiologist’s reading described findings suggestive of acute infiltrate. Patients were defined as having a primary urinary tract focus when the urine and blood culture contained the same species. According to Danish law, approval of the Regional Ethics Committee was not required. The study was included in the simplified registration of Region Zealand at the Danish Data Protection Agency (Journal number 2008-58-0020).
The R statistical software was used. The 95% binomial confidence intervals on the binomial probabilities were calculated by the “Wilson” method (Command binom.confint, library binom, http://www.r-project.org).
Pneumonic infiltrates on chest radiography
77 (80%, 71–87)
27 (35%, 25–46)
50 (65%, 54–75)
11 (56%, 39–80)
3 (27%, 10–57)
8 (73%, 43–90)
CXR was available in 77% of bacteremic episodes (80% of E.coli and 56% of K.pneumoniae) (Table 1). Among these, infiltrates were identified in 34% (35% E.coli and 30% K.pneumoniae). Furthermore, CXR was performed in 44 (85%) of the 52 episodes of E.coli bacteremia with confirmed primary urinary tract focus. Among these an infiltrate was also present in 34% (15/44).
Localizations of infiltrates were only analysed for episodes of E.coli bacteremia as only three patients with K.pneumoniae had infiltrates. The two most frequent localizations of infiltrates among bacteremic episodes caused by E.coli were lower lobe/basal (56%) and diffuse (22%). Furthermore, 30% of infiltrates were bilateral while 40% were present on the right lung and 30% on the left lung.
Bacteremia with verified microbiologic focus, N (%, 95% binomial confidence intervals)
52/66 (79%, 58–87)
6/11 (55%, 28–79)
Lower respiratory tract samples were obtained in 2% (E.coli) and 0% (K.pneumoniae) of all episodes. Among patients with Gram-negative bacteremia none had a confirmed respiratory tract focus. Blood cultures were the single microbiological samples available in 32% of cases (31% of E.coli and 39% of K.pneumoniae). Furthermore, 33% of patients with pulmonary infiltrates who later on had confirmed E.coli bacteremia did not have urine samples collected.
To our knowledge articles addressing the presence of pulmonary infiltrates among patients with community acquired Gram-negative bacteremia have not previously been published. In this study 80% of all E.coli bacteremic episodes had CXR done upon admission verifying pulmonary infiltrates in 35%. Similar rates (27%) were found for K.pneumoniae but the limited number of data does not allow a certain estimate.
Antibiotic treatment for bacterial pneumonia in areas with low level of antimicrobial resistance is often not sufficient to treat other infections derived from e.g. the urinary tract or gastrointestinal tract. Therefore, the initial clinical diagnosis upon admission is crucial. This is especially the case in Scandinavia where the resistance of S.pneumonia to penicillin is still low.
A study from the County of Northern Jutland, Denmark showed that among 815 episodes of monomibrobial Gram-negative bacteremia (70% E.coli, 17% K.pneumonia) 128 (16%) did not receive any antibiotic treatment before the notification of a positive blood culture and 94 (12%) were treated with penicillin G. The presence of pulmonary infiltrates was not investigated in that study .
Only a small proportion of patients (2%) in this study had both respiratory tract and urine cultures collected, thus identification of the primary focus had to be based on the samples available. Ideally both samples should be collected, without unnecessary delay, before initiation of antibiotic treatment in order to confirm the primary focus. Surprisingly, 31% of E.coli and 39% of K.pneumoniae bacteremic episodes did not have any supplementary microbiological samples collected apart from blood cultures.
It is well known that Gram-negative sepsis may cause acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) . A possible immunological explanation could be LPS (lipopolysaccharide) induced neutrophil recruitment to the lungs. LPS has been identified as a reliable indicator of Gram-negative bacteremia comparable to blood cultures  but whether LPS concentrations are correlated with the presence of pulmonary infiltrates has not been studied.
In vivo studies have shown that LPS activates macrophages and epithelial cells regardless of the route of administration [4, 5]. This triggers a chemotactic inflammatory response with production of proinflammatory cytokines and oxygen metabolites which causes an influx of neutrophils into the airways. Platelets adhere to vascular wall causing endothelial damage and increased permeability [4–6]. Reactive oxidants may lead to ARDS which is caused by an imbalance between oxidants and endogenous antioxidants [7, 8]. The immunologic response to LPS exposure from different Enterobacteriacea is not the same which has recently been shown to have prognostic value .
Another possible pathophysiological explanation for the inflammatory cascades in the lungs after exposure to Gram-negative bacteria is mediated by flagellin, a component of bacterial flagella. In a small sample of patients (N = 16) flagellin level was correlated to lung injury score, alveolar-arterial oxygen difference and duration of septic shock. Furthermore, flagellin was found to be a more potent stimulus than LPS for the release of proinflammatory cytokines in the lungs of mice .
A weakness of this study is that patient characteristics were not analyzed in relation to primary clinical diagnosis, co-morbidity or severity scores. Furthermore, microbiological samples were not systematically collected. These parameters should be included in future studies. However, the primary purpose of our study has been achieved showing that overall pulmonary infiltrates on CXR, whatever the cause, are very frequent among patients admitted with Gram-negative community acquired bacteremia in our population.
This study has shown that pulmonary infiltrates are common among patients with community acquired Gram-negative bacteremia in Denmark. The study also showed that only a small number of our patients had both urine and respiratory tract samples collected. Emergency room physicians should have this in mind when treating patients with community acquired sepsis as focus identification and initial diagnosis is important to initiate effective antimicrobial therapy as early as possible. These findings could have an important impact on initial patient assessment in the emergency department if supported by future studies.
Both HFN and RBD are medical specialists in Medical Microbiology. The idea of this article originated after years of consulting clinicians on optimal antibiotic treatment and focus identification of septic patients with documented bacteremia. The primary clinical diagnosis was often found to be pneumonia even when microbiological samples clearly indicated bacteremia originating from the urinary tract. This initial discrepancy is well known among medical microbiologists in Denmark even though no articles have yet been published on the subject.
All authors have made a substantial contribution to the study and all authors endorse the data and conclusions. We would like to thank Dr. Nina Friis-Møller, Odense University Hospital, Denmark for her comments to improve the manuscript.
- Pedersen G, Schønheider HC, Sørensen HT: Antibiotic therapy and outcome of monomicrobial gram-negative bacteremia: a 3-year population-based study. Scand J Infect Dis. 1997, 29: 601-606. 10.3109/00365549709035903.View ArticlePubMedGoogle Scholar
- Kollef MH, Schuster DP: The acute respiratory distress syndrome. N Engl J Med. 1995, 332: 27-37. 10.1056/NEJM199501053320106.View ArticlePubMedGoogle Scholar
- van Deventer SJ, Buller HR, ten Cate JW, Sturk A, Pauw W: Endotoxaemia: an early predictor of septicaemia in febrile patients. Lancet. 1988, 1: 605-609.View ArticlePubMedGoogle Scholar
- Brigham KL, Meyrick B: Endotoxin and lung injury. Am Rev Respir Dis. 1986, 133: 913-927.PubMedGoogle Scholar
- Tauseef M, Knezevic N, Chava KR, Smith M, Sukriti S, Gianaris N, et al: TLR4 activation of TRPC6-dependent calcium signaling mediates endotoxin-induced lung vascular permeability and inflammation. J Exp Med. 2012, 209: 1953-1968. 10.1084/jem.20111355.PubMed CentralView ArticlePubMedGoogle Scholar
- Reiss LK, Uhlig U, Uhlig S: Models and mechanisms of acute lung injury caused by direct insults. Eur J Cell Biol. 2012, 91: 590-601. 10.1016/j.ejcb.2011.11.004.View ArticlePubMedGoogle Scholar
- Chen H, Bai C, Wang X: The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine. Expert Rev Respir Med. 2010, 4: 773-783. 10.1586/ers.10.71.View ArticlePubMedGoogle Scholar
- Sabarirajan J, Vijayaraj P, Nachiappan V: Induction of acute respiratory distress syndrome in rats by lipopolysaccharide and its effect on oxidative stress and antioxidant status in lung. Indian J Biochem Biophys. 2010, 47: 278-284.PubMedGoogle Scholar
- Hurley JC, Opal SM: Prognostic value of endotoxemia in patients with Gram-negative bacteremia is bacterial species dependent. J Innate Immun. 2013, [Epub ahead of print]Google Scholar
- Liaudet L, Szabó C, Evgenov OV, Murthy KG, Pacher P, Virág L, et al: Flagellin from gram-negative bacteria is a potent mediator of acute pulmonary inflammation in sepsis. Shock. 2003, 19: 131-137. 10.1097/00024382-200302000-00008.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.